Intelligent Bio Solutions Files 8-K
Ticker: INBS · Form: 8-K · Filed: Sep 26, 2025 · CIK: 1725430
Sentiment: neutral
Topics: 8-K, corporate-filing, regulation-fd
TL;DR
IBSI filed an 8-K on 9/26/25, standard corporate update.
AI Summary
Intelligent Bio Solutions Inc. filed an 8-K on September 26, 2025, reporting under Regulation FD and including financial statements and exhibits. The company, formerly known as GBS Inc. and Glucose Biosensor Systems (Greater China) Holdings, Inc., is incorporated in Delaware and has its principal executive offices in New York, NY.
Why It Matters
This filing indicates routine corporate reporting, including financial updates and regulatory disclosures, which are important for investors to monitor the company's status.
Risk Assessment
Risk Level: low — This is a standard 8-K filing for corporate reporting and does not appear to contain any immediately concerning information.
Key Players & Entities
- INTELLIGENT BIO SOLUTIONS INC. (company) — Registrant
- GBS Inc. (company) — Former company name
- Glucose Biosensor Systems (Greater China) Holdings, Inc. (company) — Former company name
- September 26, 2025 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
When was this report filed?
This report was filed on September 26, 2025.
What are the previous names of Intelligent Bio Solutions Inc.?
The previous names of Intelligent Bio Solutions Inc. were GBS Inc. and Glucose Biosensor Systems (Greater China) Holdings, Inc.
Where are the principal executive offices of Intelligent Bio Solutions Inc. located?
The principal executive offices are located at 135 West 41st Street, 5th Floor, New York, NY 10036.
What is the Standard Industrial Classification code for Intelligent Bio Solutions Inc.?
The Standard Industrial Classification code is 3841, for Surgical & Medical Instruments & Apparatus.
Filing Stats: 529 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2025-09-26 08:45:53
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value INBS The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 36KB
- ex99-1.htm (EX-99.1) — 14KB
- 0001493152-25-015068.txt ( ) — 218KB
- inbs-20250926.xsd (EX-101.SCH) — 3KB
- inbs-20250926_lab.xml (EX-101.LAB) — 33KB
- inbs-20250926_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 26, 2025 INTELLIGENT BIO SOLUTIONS INC. By: /s/ Spiro Sakiris Name: Spiro Sakiris Title: Chief Financial Officer